Biological potency and uterine estrogen receptor interactions of the metabolites of the antiestrogens CI628 and U23,469.
D000818:Animals; D001667:Binding, Competitive; D002467:Cell Nucleus / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D004965:Estrogen Antagonists / Q000378:metabolism / Q000494:pharmacology*; D005260:Female; D009281:Naphthalenes / Q000494:pharmacology*; D009594:Nitromifene / Q000378:metabolism / Q000494:pharmacology*; D010544:Peroxidases / Q000378:metabolism; D011409:Propylene Glycols / Q000378:metabolism / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D011960:Receptors, Estrogen / Q000187:drug effects*; D013764:Tetrahydronaphthalenes / Q000378:metabolism / Q000494:pharmacology*; D014590:Uterine Contraction / Q000187:drug effects; D014599:Uterus / Q000378:metabolism*
D004965:Estrogen Antagonists; D009281:Naphthalenes; D011409:Propylene Glycols; D011759:Pyrrolidines; D011960:Receptors, Estrogen; D013764:Tetrahydronaphthalenes; C014291:U 23469; D009594:Nitromifene; D010544:Peroxidases